Stock 300705 HUNAN JIUDIAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hunan Jiudian Pharmaceutical Co., Ltd.

Equities

300705

CNE1000034Z6

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 08/05/2024 am IST 		5-day change 1st Jan Change
38.46 CNY -0.23% Intraday chart for Hunan Jiudian Pharmaceutical Co., Ltd. +2.94% +15.74%
24/04 Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
26/01 Hunan Jiudian Pharmaceutical Co., Ltd. Elects Yang Yang and Fan Pengyun as Non-Independent Director CI

Business Summary

Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Company’s products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.

Number of employees: 1,893

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Preparations
83.1 %
1,930 83.0 % 2,236 83.1 % +15.86%
Medical Supplements
6.5 %
164 7.0 % 176 6.5 % +7.56%
Active Pharmaceutical Ingredients
6.2 %
129 5.5 % 168 6.2 % +29.87%
Plant Extracts and Others
2.7 %
60 2.6 % 73 2.7 % +21.60%
Technology Transfer and Services
1.4 %
42 1.8 % 38 1.4 % -8.40%
Other Business
0.0 %
1 0.0 % 1 0.0 % +14.17%
Software Development and Maintenance Fees
0.0 %
1 0.0 % 0 0.0 % -68.07%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.2 %
2,282 98.1 % 2,643 98.2 % +15.82%
International
1.8 %
43 1.8 % 48 1.8 % +11.75%
Global
0.0 %
1 0.0 % 1 0.0 % +14.17%

Managers

Managers TitleAgeSince
Xia Hui Zheng CEO
 Chief Executive Officer 63 01/03/01
Ying Xiong DFI
 Director of Finance/CFO 60 01/07/01
Sheng Hua Liang BRD
 Director/Board Member 47 01/01/01
Shang Lu BRD
 Director/Board Member 45 01/06/01
Zhi Yun Zhu BRD
 Director/Board Member 57 01/01/01
Rong Gan IRC
 Investor Relations Contact - -
Lei Zeng SEC
 Corporate Secretary 39 01/14/01

Members of the board

Members of the board TitleAgeSince
Zhi Hong Zhu CHM
 Chairman 61 01/01/01
Li Xin Duan BRD
 Director/Board Member 60 01/01/01
Zhi Yun Zhu BRD
 Director/Board Member 57 01/01/01
Xia Hui Zheng CEO
 Chief Executive Officer 63 01/03/01
Bin Duan CHM
 Chairman 59 01/10/01
Shang Lu BRD
 Director/Board Member 45 01/06/01
Sheng Hua Liang BRD
 Director/Board Member 47 01/01/01
Qiu Lin Yang BRD
 Director/Board Member 60 15/21/15
Jing Xiang BRD
 Director/Board Member 48 15/21/15
Cong Shan Zhou BRD
 Director/Board Member 49 15/21/15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 345,148,416 168,167,186 ( 48.72 %) 0 48.72 %

Shareholders

NameEquities%Valuation
Zhi Hong Zhu
14.08 %
29,368,500 14.08 % 153 M ¥
China Merchants Fund Management Co., Ltd.
10.04 %
20,942,573 10.04 % 109 M ¥
Essence Fund Co., Ltd.
6.394 %
13,335,884 6.394 % 69 M ¥
Li Fang Chen
3.240 %
6,758,800 3.240 % 35 M ¥
Li Xin Duan
2.804 %
5,849,189 2.804 % 30 M ¥
Guotai Asset Management Co., Ltd.
1.633 %
3,406,075 1.633 % 18 M ¥
CHINA EVERBRIGHT BANK COMPANY LIMITED
1.588 %
3,313,296 1.588 % 17 M ¥
Ju Bo Lu
1.412 %
2,945,000 1.412 % 15 M ¥
Great Wall Fund Management Co., Ltd.
1.292 %
2,694,600 1.292 % 14 M ¥
China Southern Asset Management Co., Ltd.
1.014 %
2,114,200 1.014 % 11 M ¥
NameEquities%Valuation
Zhi Hong Zhu
68.02 %
88,105,500 68.02 % 458 M ¥
Li Xin Duan
28.39 %
36,776,929 28.39 % 191 M ¥
Zhi Yun Zhu
1.617 %
2,094,472 1.617 % 11 M ¥
Xia Hui Zheng
1.065 %
1,378,828 1.065 % 7 M ¥
Ying Xiong
0.3392 %
439,349 0.3392 % 2 M ¥

Company contact information

Hunan Jiudian Pharmaceutical Co., Ltd.

Building A1, Jinrui Lugu Sci & Tech No. 28 Lutian Road

410205, Changsha

+

http://www.hnjiudian.com
address Hunan Jiudian Pharmaceutical Co., Ltd.(300705)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Hunan Jiudian Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
38.46
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUNAN JIUDIAN PHARMACEUTICAL CO., LTD. Stock Hunan Jiudian Pharmaceutical Co., Ltd.
+15.74% 1.84B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.95% 700B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.97% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.83% 330B
ABBVIE INC. Stock AbbVie Inc.
+3.54% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.70% 236B
NOVARTIS AG Stock Novartis AG
+6.68% 202B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 197B
AMGEN INC. Stock Amgen Inc.
+6.70% 161B
PFIZER, INC. Stock Pfizer, Inc.
-1.81% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300705 Stock
  4. Company Hunan Jiudian Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW